in vitro News and Research

RSS

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.

1 Feb 2019

Enhancing HD-MEA Systems with CMOS

At SfN 2018, we spoke to MaxWell Biosystems about their CMOS based HD-MEA systems for recording and stimulating electrogenic cells in-vitro - MaxOne and MaxTwo.

From MaxWell Biosystems 31 Jan 2019

EKF signs private label distribution agreement with McKesson for new hemoglobin analyzer

EKF Diagnostics has signed a private label distribution agreement with McKesson Medical-Surgical Inc.

From EKF Diagnostics 30 Jan 2019

Cancer cure within a year, claims Israeli team

A team of Israeli scientists belonging to a company called the Accelerated Evolution Biotechnologies (AEBi) have claimed to be at a stage where they can find a cure for cancer within a year. The therapy is being developed under the leadership of the CEO of AEBi, Dr. Ilan Morad.

29 Jan 2019

New drug compounds show promise in treating acute myeloid leukemia

Researchers have been struggling for years to find a treatment for patients who have a recurrence of acute myeloid leukemia (AML), an aggressive blood cancer that is one of the most lethal cancers. About 19,520 news cases are diagnosed a year, and about 10,670 people a year die from it, according to the American Cancer Society.

29 Jan 2019

New study may help develop corrective mechanisms for neurodegenerative diseases, ischemia

In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.In the last decade, there has been a growing body of experimental data confirming that neural networks are the minimal functional unit of the nervous system.

29 Jan 2019

EU research project is studying the effect of endocrine disruptors on metabolism

January 2019 saw the launch of the EU research project EDCMET, in which scientists from the German Federal Institute for Risk Assessment (BfR) are also involved.

28 Jan 2019

New class of antisense oligonucleotide therapeutics tested in humans

A first-in-human study with a new class of antisense oligonucleotide therapeutics showed the ability to target the RNA-silencing drug to the liver, resulting in improved potency and safety at therapeutic doses. The design and results of this trial, conducted in healthy human volunteers are reported in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

28 Jan 2019

Reassuring findings on the link between antidepressants and fertility

Based on limited research, there's no strong evidence that selective serotonin-reuptake inhibitors (SSRIs) - the most widely used class of antidepressants - have an adverse impact on fertility, according to a paper in the Harvard Review of Psychiatry.

25 Jan 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

Norwegian scientists discover new small molecule drug to treat prostate cancer

Professor Fahri Saatcioglu at University of Oslo's Department of Biosciences (IBV) heads a research group investigating how androgens - male sex hormones - affect the risk of being affected by prostate cancer.

24 Jan 2019

Researchers reveal important signaling pathway in breast cancer

Researchers at Kanazawa University report in Proceedings of the National Academy of Sciences of the United States of America that a particular signaling pathway in breast-cancer tumors causes cancer cells to divide symmetrically, expanding the tumor. Inhibiting the pathway by drugs could become a strategy for eliminating the cancer cells.

24 Jan 2019

Study: Long-term spaceflights could adversely affect astronauts' immune systems

NASA hopes to send humans to Mars by 2030 on a round-trip mission that could take up to three years - far longer than any human has ever traveled in space.

24 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath

Diseases such as multiple sclerosis are characterized by damage to the 'myelin sheath', a protective covering wrapped around nerve cells akin to insulation around an electrical wire.

22 Jan 2019

Graphene Flagship project studies impact of graphene and related materials on our health

As the drive to commercialize graphene continues, it is important that all safety aspects are thoroughly researched and understood.

22 Jan 2019

Sartorius launches BIOSTAT RM TX single-use bioreactor for consistent quality cellular products

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry today announced the launch of the BIOSTAT RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.

From Sartorius 22 Jan 2019

in vitro News and Research

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

Enhancing HD-MEA Systems with CMOS

EKF signs private label distribution agreement with McKesson for new hemoglobin analyzer

Cancer cure within a year, claims Israeli team

New drug compounds show promise in treating acute myeloid leukemia

New study may help develop corrective mechanisms for neurodegenerative diseases, ischemia

EU research project is studying the effect of endocrine disruptors on metabolism

New class of antisense oligonucleotide therapeutics tested in humans

Reassuring findings on the link between antidepressants and fertility

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Norwegian scientists discover new small molecule drug to treat prostate cancer

Researchers reveal important signaling pathway in breast cancer

Study: Long-term spaceflights could adversely affect astronauts' immune systems

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath

Graphene Flagship project studies impact of graphene and related materials on our health

Sartorius launches BIOSTAT RM TX single-use bioreactor for consistent quality cellular products

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs

New project finds how endocrine disruptors interfere with thyroid functions

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News